These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3192636)

  • 21. HM-PAO brain SPECT and epilepsy.
    Biersack HJ; Stefan H; Reichmann K; Linke D; Kurthen M; Kropp J; Penin H
    Nucl Med Commun; 1987 Jul; 8(7):513-8. PubMed ID: 3500432
    [No Abstract]   [Full Text] [Related]  

  • 22. Changes in cerebral perfusion after acute head injury: comparison of CT with Tc-99m HM-PAO SPECT.
    Abdel-Dayem HM; Sadek SA; Kouris K; Bahar RH; Higazi I; Eriksson S; Englesson SH; Berntman L; Sigurdsson GH; Foad M
    Radiology; 1987 Oct; 165(1):221-6. PubMed ID: 3498184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical usefulness of technetium-99m HM-PAO labeled white blood cell imaging in abscesses.
    Mortelmans L; Verbruggen A; Augustinus J; Wilms G; De Roo M
    Clin Nucl Med; 1989 Feb; 14(2):127-9. PubMed ID: 2731392
    [No Abstract]   [Full Text] [Related]  

  • 24. Cerebral perfusion imaging.
    Ballinger JR; Gulenchyn KY
    J Nucl Med; 1987 Aug; 28(8):1364-5. PubMed ID: 3039085
    [No Abstract]   [Full Text] [Related]  

  • 25. Technetium 99m-hexamethyl propyleneamine oxime-labeled leukocytes for diagnosis of infection.
    Datz FL
    West J Med; 1992 Jul; 157(1):60-1. PubMed ID: 1413746
    [No Abstract]   [Full Text] [Related]  

  • 26. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease.
    Perani D; Di Piero V; Vallar G; Cappa S; Messa C; Bottini G; Berti A; Passafiume D; Scarlato G; Gerundini P
    J Nucl Med; 1988 Sep; 29(9):1507-14. PubMed ID: 3261784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of flow and rate constants in a kinetic model of [99mTc]-hexamethyl-propylene amine oxime in the human brain.
    Matsuda H; Oba H; Seki H; Higashi S; Sumiya H; Tsuji S; Terada H; Imai K; Shiba K; Mori H
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S61-8. PubMed ID: 3192643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HM-PAO in clinical practice.
    Podreka I
    Nucl Med Commun; 1987 Jul; 8(7):559-72. PubMed ID: 3500435
    [No Abstract]   [Full Text] [Related]  

  • 29. [Basic and clinical studies of brain perfusion scintigraphy using 99mTc-d,l-hexamethyl-propyleneamine oxime].
    Matsuda H; Terada H; Higashi S; Sumiya H; Tsuji S; Seki H; Oba H; Fujii H; Ikeda K; Imai K
    Kaku Igaku; 1987 Sep; 24(9):1329-41. PubMed ID: 3501813
    [No Abstract]   [Full Text] [Related]  

  • 30. Kinetic analysis of technetium-99m d,1-HM-PAO decomposition in aqueous media.
    Hung JC; Corlija M; Volkert WA; Holmes RA
    J Nucl Med; 1988 Sep; 29(9):1568-76. PubMed ID: 3411374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of technetium-99m HM-PAO for determination of brain death.
    Reid RH; Gulenchyn KY; Ballinger JR
    J Nucl Med; 1989 Oct; 30(10):1621-6. PubMed ID: 2795202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Scintigraphic demonstration of inflammatory processes with 99m-Tc-HM-PAO-labeled leukocytes].
    Bülow J
    Ugeskr Laeger; 1987 Dec; 149(50):3403-4. PubMed ID: 3433542
    [No Abstract]   [Full Text] [Related]  

  • 33. Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.
    Neirinckx RD; Canning LR; Piper IM; Nowotnik DP; Pickett RD; Holmes RA; Volkert WA; Forster AM; Weisner PS; Marriott JA
    J Nucl Med; 1987 Feb; 28(2):191-202. PubMed ID: 3492596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 99mTc-hexamethylpropyleneamine oxime scans to confirm brain death.
    Roine RO; Launes J; Lindroth L; Nikkinen P
    Lancet; 1986 Nov; 2(8517):1223-4. PubMed ID: 2877363
    [No Abstract]   [Full Text] [Related]  

  • 35. The study of regional cerebral blood flow in stroke patients using technetium 99m HMPAO.
    Smith FW; Donald RT; Morris AJ; Sharp PF; Gemmell HG
    Br J Radiol; 1988 May; 61(725):358-61. PubMed ID: 3382864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Basic and clinical evaluation of regional cerebral perfusion scintigraphy of 99mTc-HM-PAO].
    Tsukatani Y; Nakamura K; Fujii H; Yorozu A; Ogawa K; Kunieda E; Kubo A; Hashimoto S; Terayama Y; Amano T
    Rinsho Hoshasen; 1988 Jul; 33(7):741-9. PubMed ID: 3266260
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative study of the brain uptake and early kinetics of 99mTc-dl HM-PAO and other PnAO derivatives in baboons.
    Reichmann K; Biersack HJ; Basso L; Hartmann A; Matthews IT; Neirinckx RD; Pickett RD; Winkler C
    Nuklearmedizin; 1986 Aug; 25(4):134-7. PubMed ID: 3489925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical application of 99mTc-HM-PAO in cerebral blood flow imaging by SPECT--comparison with cerebral blood flow study by PET].
    Inugami A; Uemura K; Shishido F; Tomura N; Higano S; Fujita H; Kanno I
    Rinsho Hoshasen; 1988 Feb; 33(2):243-8. PubMed ID: 3260297
    [No Abstract]   [Full Text] [Related]  

  • 39. [99mTc-HMPAO pharmacokinetics in probands. Initial experiences with planar cerebral perfusion scintigraphy].
    Deckart H; Ertl S; Bratouss A; Tambor A
    Radiobiol Radiother (Berl); 1988; 29(2):237-42. PubMed ID: 3399665
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of vasospasm secondary to subarachnoid hemorrhage with technetium-99m-hexamethyl-propyleneamine oxime (HM-PAO) tomoscintigraphy.
    Soucy JP; McNamara D; Mohr G; Lamoureux F; Lamoureux J; Danais S
    J Nucl Med; 1990 Jun; 31(6):972-7. PubMed ID: 2348242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.